Therapy of sepsis
Authors:
- 1 August 1999
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 27 (8) , 1682-1683
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical Gram-positive sepsisCritical Care Medicine, 1999
- Functional Analysis of Monocyte Subsets in Surgical SepsisThe Journal of Trauma: Injury, Infection, and Critical Care, 1998
- ANIMAL MODELS OF SEPSIS AND SHOCKShock, 1998
- ANTI-INTERLEUKIN-12 THERAPY PROTECTS MICE IN LETHAL ENDOTOXEMIA BUT IMPAIRS BACTERIAL CLEARANCE IN MURINE ESCHERICHIA COLI PERITONEAL SEPSISShock, 1997
- Multiple Organ Failure, Multiple Organ Dysfunction Syndrome, and Systemic Inflammatory Response SyndromeArchives of Surgery, 1997
- Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsisCritical Care Medicine, 1996
- The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.Proceedings of the National Academy of Sciences, 1995
- Gram-positive Organisms and SepsisArchives of internal medicine (1960), 1994
- Choice of bacteria in animal models of sepsisInfection and Immunity, 1993
- Influenza B virus infection associated with non-bacterial septic shock-like illnessJournal of Infection, 1992